Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer
- PMID: 18390755
- DOI: 10.4049/jimmunol.180.8.5699
Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer
Abstract
Arrestins are adaptor/scaffold proteins that complex with activated and phosphorylated G protein-coupled receptor to terminate G protein activation and signal transduction. These complexes also mediate downstream signaling, independently of G protein activation. We have previously shown that beta-arrestin-2 (betaarr2) depletion promotes CXCR2-mediated cellular signaling, including angiogenesis and excisional wound closure. This study was designed to investigate the role of betaarr2 in tumorigenesis using a murine model of lung cancer. To that end, heterotopic murine Lewis lung cancer and tail vein metastasis tumor model systems in betaarr2-deficient mice (betaarr2(-/-)) and control littermates (betaarr2(+/+)) were used. betaarr2(-/-) mice exhibited a significant increase in Lewis lung cancer tumor growth and metastasis relative to betaarr2(+/+) mice. This correlated with decreased number of tumor-infiltrating lymphocytes but with elevated levels of the ELR(+) chemokines (CXCL1/keratinocyte-derived chemokine and CXCL2/MIP-2), vascular endothelial growth factor, and microvessel density. NF-kappaB activity was also enhanced in betaarr2(-/-) mice, whereas hypoxia-inducible factor-1alpha expression was decreased. Inhibition of CXCR2 or NF-kappaB reduced tumor growth in both betaarr2(-/-) and betaarr2(+/+) mice. NF-kappaB inhibition also decreased ELR(+) chemokines and vascular endothelial growth factor expression. Altogether, the data suggest that betaarr2 modulates tumorigenesis by regulating inflammation and angiogenesis through activation of CXCR2 and NF-kappaB.
Similar articles
-
G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.J Immunol. 2013 May 15;190(10):5329-36. doi: 10.4049/jimmunol.1202058. Epub 2013 Apr 15. J Immunol. 2013. PMID: 23589623 Free PMC article.
-
Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.J Immunol. 2005 Oct 15;175(8):5396-402. doi: 10.4049/jimmunol.175.8.5396. J Immunol. 2005. PMID: 16210646 Free PMC article.
-
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.J Immunol. 2004 Mar 1;172(5):2853-60. doi: 10.4049/jimmunol.172.5.2853. J Immunol. 2004. PMID: 14978086
-
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.Int J Mol Sci. 2021 Jan 15;22(2):843. doi: 10.3390/ijms22020843. Int J Mol Sci. 2021. PMID: 33467722 Free PMC article. Review.
-
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.Ann N Y Acad Sci. 2004 Dec;1028:351-60. doi: 10.1196/annals.1322.041. Ann N Y Acad Sci. 2004. PMID: 15650260 Review.
Cited by
-
β-arrestin-2 alleviates rheumatoid arthritis injury by suppressing NLRP3 inflammasome activation and NF- κB pathway in macrophages.Bioengineered. 2022 Jan;13(1):38-47. doi: 10.1080/21655979.2021.2003678. Bioengineered. 2022. PMID: 34787064 Free PMC article.
-
Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells.PLoS One. 2011 May 12;6(5):e19585. doi: 10.1371/journal.pone.0019585. PLoS One. 2011. PMID: 21589858 Free PMC article.
-
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.Cancer Res. 2013 Jan 15;73(2):571-82. doi: 10.1158/0008-5472.CAN-12-0263. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204236 Free PMC article.
-
C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.Cell Cycle. 2019 Dec;18(24):3456-3471. doi: 10.1080/15384101.2019.1689471. Epub 2019 Nov 15. Cell Cycle. 2019. PMID: 31731888 Free PMC article.
-
β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.Front Immunol. 2020 Sep 18;11:550824. doi: 10.3389/fimmu.2020.550824. eCollection 2020. Front Immunol. 2020. PMID: 33072091 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases